NEWS & PERSPECTIVES
Psychedelics News
Curated updates on microdosing, research, policy, and community.
The latest
Psychedelics Restructure the Global Workspace of Consciousness
This preprint reanalysed resting-state brain scans from two crossover studies in healthy volunteers, finding that LSD, psilocybin and mescaline were associated with more model-defined “gateway” regions in frontopariet...
Dose-dependent modulation of visual imagery by Ayahuasca and dampening of visual processing away from external input: a placebo-controlled pharmacoimaging study
This placebo-controlled fMRI study (n=11) found that ayahuasca increased simple and complex visual imagery in a dose-dependent way. At higher doses, it reduced activity in some brain regions that respond to strong vis...
An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder
In this unblinded randomised waitlist-controlled preprint, 37 people with OCD were assigned to immediate or delayed psilocybin and 30 completed the one-month analysis; a 20 mg session was followed by 30 mg if tolerate...
Dose-dependent modulation of visual imagery by Ayahuasca and dampening of visual processing away from external input: a placebo-controlled pharmacoimaging study
This placebo-controlled fMRI study (n=11) found that ayahuasca increased simple and complex visual imagery in a dose-dependent way. At higher doses, it reduced activity in some brain regions that respond to strong vis...
What I Learned Reviewing 100+ Psychedelic Organizations
This Week’s Sunday Insider: The questions arriving in my inbox, what organizations tell me when I ask for details & why recommending someone is harder than rating their website.
Virtual reality can induce mystical experiences, new study suggests
Virtual reality headsets might offer a reliable way to induce profound feelings of unity and awe typically associated with deep spiritual practices or psychedelics, providing researchers with a new tool to study human...
Psychedelic Churches Need Psychedelic Seminaries
The psychedelic field has built institutions for studying molecules, delivering therapies, and training facilitators. Paul Ryder, founder of the Congregation for Sacred Practices, argues that what it still lacks is a ...
Tell the FDA What Psychedelic Care Should Look Like. You Have Until Monday.
A veteran's recovery from 10-out-of-10 pain shows what the agency's psychiatric model misses, and why your experience belongs in the record.
Psilocybin in the UK: Research, Regulation and Access Landscape in 2026
This article was originally published on Mind Forward.
A dispatch from Tuesday’s MAHA Summit
Plus: “People who qualify will never get in” to New Mexico’s psilocybin program; Ketamine in clinical vs non-clinical settings
7 Questions I'm Obsessed With About Psychedelics Right Now
Welcome to The Psychedelic Blog. An independent media platform covering drugs, altered states & the culture surrounding them.
The Heated Debate Over How Psychedelics Work in the Brain
The entropic brain hypothesis has been the leading explanation for how psychedelics work in the brain, but new research suggests it's not that simple. [...] Read More...
Quarterly Psychedelics Briefing: Q3 2026
Welcome to our Q3 2026 Quarterly Briefing. Every three months, our Founder & Editor Josh Hardman walks you through major developments from the prior quarter across drug development, policy and regulation, science and ...
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LONDON & NEW YORK, October 02, 2026--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today…
Is HHS too cosy with the psychedelic industry?
And is the American public being misled on psychedelic risks?